Royal Bank of Canada’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,622
Closed -$15K 7878
2023
Q4
$15K Buy
2,622
+1,949
+290% +$23.1K ﹤0.01% 6410
2023
Q3
$18K Buy
673
+113
+20% +$9.29K ﹤0.01% 6227
2023
Q2
$78K Buy
560
+251
+81% +$32.2K ﹤0.01% 5525
2023
Q1
$28K Sell
309
-111
-26% -$15.1K ﹤0.01% 5901
2022
Q4
$58K Buy
420
+277
+194% +$93.8K ﹤0.01% 5795
2022
Q3
$124K Buy
143
+120
+522% +$75.2K ﹤0.01% 5173
2022
Q2
$10K Sell
23
-55
-71% -$28.7K ﹤0.01% 6402
2022
Q1
$50K Sell
78
-142
-65% -$89.5K ﹤0.01% 6110
2021
Q4
$196K Sell
220
-327
-60% -$344K ﹤0.01% 5355
2021
Q3
$694K Buy
547
+533
+3,807% +$646K ﹤0.01% 4053
2021
Q2
$17K Hold
14
﹤0.01% 6659
2021
Q1
$19K Sell
14
-90
-87% -$127K ﹤0.01% 6463
2020
Q4
$139K Buy
104
+89
+593% +$102K ﹤0.01% 5128
2020
Q3
$16K Buy
+15
New +$15.7K ﹤0.01% 5779

Other funds holding CANO

Royal Bank of Canada's CANO Position: Q1 2024 in Review

Royal Bank of Canada sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 2,622 shares — an estimated $15K sold.

Royal Bank of Canada first reported a position in CANO in Q3 2020 and held it in 14 quarters. The position peaked at $694K in Q3 2021. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Royal Bank of Canada reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 2,622 Cano Health, Inc. shares in Q1 2024, an estimated $15K.
  • Royal Bank of Canada first reported a position in Cano Health, Inc. in Q3 2020 and held it in 14 quarters.
  • Royal Bank of Canada's Cano Health, Inc. position peaked at $694K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.